1 Hormonal Contraception Market Overview

• 1.1 Product Overview and Scope of Hormonal Contraception
• 1.2 Hormonal Contraception Segment by Hormone
  • 1.2.1 Global Hormonal Contraception Sales Growth Rate Comparison by Hormone (2021-2027)
  • 1.2.2 Androgens
  • 1.2.3 Estrogens
  • 1.2.4 Progestrogens
  • 1.2.5 Antiandrogens
  • 1.2.6 Gonadotropins
• 1.3 Hormonal Contraception Segment by Application
  • 1.3.1 Hormonal Contraception Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinics
  • 1.3.4 Gynaecology Centers
  • 1.3.5 Others
• 1.4 Global Hormonal Contraception Market Size Estimates and Forecasts
  • 1.4.1 Global Hormonal Contraception Revenue 2016-2027
  • 1.4.2 Global Hormonal Contraception Sales 2016-2027
  • 1.4.3 Hormonal Contraception Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hormonal Contraception Market Competition by Manufacturers

• 2.1 Global Hormonal Contraception Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Hormonal Contraception Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Hormonal Contraception Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Hormonal Contraception Manufacturing Sites, Area Served, Product Type
• 2.5 Hormonal Contraception Market Competitive Situation and Trends
  • 2.5.1 Hormonal Contraception Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Hormonal Contraception Players Market Share by Revenue
  • 2.5.3 Global Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hormonal Contraception Retrospective Market Scenario by Region

• 3.1 Global Hormonal Contraception Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Hormonal Contraception Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Hormonal Contraception Market Facts & Figures by Country
  • 3.3.1 North America Hormonal Contraception Sales by Country
  • 3.3.2 North America Hormonal Contraception Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Hormonal Contraception Market Facts & Figures by Country
  • 3.4.1 Europe Hormonal Contraception Sales by Country
  • 3.4.2 Europe Hormonal Contraception Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Hormonal Contraception Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Hormonal Contraception Sales by Region
  • 3.5.2 Asia Pacific Hormonal Contraception Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Hormonal Contraception Market Facts & Figures by Country
  • 3.6.1 Latin America Hormonal Contraception Sales by Country
  • 3.6.2 Latin America Hormonal Contraception Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Hormonal Contraception Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Hormonal Contraception Sales by Country
  • 3.7.2 Middle East and Africa Hormonal Contraception Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Hormonal Contraception Historic Market Analysis by Type

• 4.1 Global Hormonal Contraception Sales Market Share by Type (2016-2021)
• 4.2 Global Hormonal Contraception Revenue Market Share by Type (2016-2021)
• 4.3 Global Hormonal Contraception Price by Type (2016-2021)

5 Global Hormonal Contraception Historic Market Analysis by Application

• 5.1 Global Hormonal Contraception Sales Market Share by Application (2016-2021)
• 5.2 Global Hormonal Contraception Revenue Market Share by Application (2016-2021)
• 5.3 Global Hormonal Contraception Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Bayer AG
  • 6.1.1 Bayer AG Corporation Information
  • 6.1.2 Bayer AG Description and Business Overview
  • 6.1.3 Bayer AG Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Bayer AG Product Portfolio
  • 6.1.5 Bayer AG Recent Developments/Updates
• 6.2 Merck & Co., Inc.
  • 6.2.1 Merck & Co., Inc. Corporation Information
  • 6.2.2 Merck & Co., Inc. Description and Business Overview
  • 6.2.3 Merck & Co., Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Merck & Co., Inc. Product Portfolio
  • 6.2.5 Merck & Co., Inc. Recent Developments/Updates
• 6.3 Pfizer, Inc.
  • 6.3.1 Pfizer, Inc. Corporation Information
  • 6.3.2 Pfizer, Inc. Description and Business Overview
  • 6.3.3 Pfizer, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Pfizer, Inc. Product Portfolio
  • 6.3.5 Pfizer, Inc. Recent Developments/Updates
• 6.4 Agile Therapeutics, Inc.
  • 6.4.1 Agile Therapeutics, Inc. Corporation Information
  • 6.4.2 Agile Therapeutics, Inc. Description and Business Overview
  • 6.4.3 Agile Therapeutics, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Agile Therapeutics, Inc. Product Portfolio
  • 6.4.5 Agile Therapeutics, Inc. Recent Developments/Updates
• 6.5 Teva Pharmaceutical Industries Ltd.
  • 6.5.1 Teva Pharmaceutical Industries Ltd. Corporation Information
  • 6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
  • 6.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Teva Pharmaceutical Industries Ltd. Product Portfolio
  • 6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
• 6.6 Amgen
  • 6.6.1 Amgen Corporation Information
  • 6.6.2 Amgen Description and Business Overview
  • 6.6.3 Amgen Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Amgen Product Portfolio
  • 6.6.5 Amgen Recent Developments/Updates
• 6.7 Cipla Ltd.
  • 6.6.1 Cipla Ltd. Corporation Information
  • 6.6.2 Cipla Ltd. Description and Business Overview
  • 6.6.3 Cipla Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Cipla Ltd. Product Portfolio
  • 6.7.5 Cipla Ltd. Recent Developments/Updates
• 6.8 Glenmark Pharmaceuticals Inc.
  • 6.8.1 Glenmark Pharmaceuticals Inc. Corporation Information
  • 6.8.2 Glenmark Pharmaceuticals Inc. Description and Business Overview
  • 6.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Glenmark Pharmaceuticals Inc. Product Portfolio
  • 6.8.5 Glenmark Pharmaceuticals Inc. Recent Developments/Updates
• 6.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)
  • 6.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Corporation Information
  • 6.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Description and Business Overview
  • 6.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Product Portfolio
  • 6.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
• 6.10 Novartis AG
  • 6.10.1 Novartis AG Corporation Information
  • 6.10.2 Novartis AG Description and Business Overview
  • 6.10.3 Novartis AG Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Novartis AG Product Portfolio
  • 6.10.5 Novartis AG Recent Developments/Updates
• 6.11 Mylan N.V.
  • 6.11.1 Mylan N.V. Corporation Information
  • 6.11.2 Mylan N.V. Hormonal Contraception Description and Business Overview
  • 6.11.3 Mylan N.V. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Mylan N.V. Product Portfolio
  • 6.11.5 Mylan N.V. Recent Developments/Updates
• 6.12 Johnson & Johnson
  • 6.12.1 Johnson & Johnson Corporation Information
  • 6.12.2 Johnson & Johnson Hormonal Contraception Description and Business Overview
  • 6.12.3 Johnson & Johnson Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Johnson & Johnson Product Portfolio
  • 6.12.5 Johnson & Johnson Recent Developments/Updates
• 6.13 Ansell LTD
  • 6.13.1 Ansell LTD Corporation Information
  • 6.13.2 Ansell LTD Hormonal Contraception Description and Business Overview
  • 6.13.3 Ansell LTD Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Ansell LTD Product Portfolio
  • 6.13.5 Ansell LTD Recent Developments/Updates
• 6.14 Mayer Laboratories, Inc.
  • 6.14.1 Mayer Laboratories, Inc. Corporation Information
  • 6.14.2 Mayer Laboratories, Inc. Hormonal Contraception Description and Business Overview
  • 6.14.3 Mayer Laboratories, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Mayer Laboratories, Inc. Product Portfolio
  • 6.14.5 Mayer Laboratories, Inc. Recent Developments/Updates

7 Hormonal Contraception Manufacturing Cost Analysis

• 7.1 Hormonal Contraception Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Hormonal Contraception
• 7.4 Hormonal Contraception Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Hormonal Contraception Distributors List
• 8.3 Hormonal Contraception Customers

9 Hormonal Contraception Market Dynamics

• 9.1 Hormonal Contraception Industry Trends
• 9.2 Hormonal Contraception Growth Drivers
• 9.3 Hormonal Contraception Market Challenges
• 9.4 Hormonal Contraception Market Restraints

10 Global Market Forecast

• 10.1 Hormonal Contraception Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Hormonal Contraception by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Hormonal Contraception by Type (2022-2027)
• 10.2 Hormonal Contraception Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Hormonal Contraception by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Hormonal Contraception by Application (2022-2027)
• 10.3 Hormonal Contraception Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Hormonal Contraception by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Hormonal Contraception by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
by Hormone
Androgens
Estrogens
Progestrogens
Antiandrogens
Gonadotropins
by Method
Combined Oral
Oral Pill
Implanted
Injected
Intrauterine
Transdermal Patch

Segment by Application
Hospital
Clinics
Gynaecology Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Bayer AG
Merck & Co., Inc.
Pfizer, Inc.
Agile Therapeutics, Inc.
Teva Pharmaceutical Industries Ltd.
Amgen
Cipla Ltd.
Glenmark Pharmaceuticals Inc.
Lupin Limited(Lupin Pharmaceuticals, Inc.)
Novartis AG
Mylan N.V.
Johnson & Johnson
Ansell LTD
Mayer Laboratories, Inc.